BackTaro Pharmaceutical Industries Overview

Taro Pharmaceutical Industries Current Cash

Latest current cash for TARO: $360M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$362.91M
↑ 134.90% YoYΔ $208.41M vs prior year quarter

Peer average / median

Loading

Taro Pharmaceutical Industries Current Cash History

Loading

Taro Pharmaceutical Industries vs. peers: Current Cash Comparison

Loading

Taro Pharmaceutical Industries Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Taro Pharmaceutical Industries (TARO) FAQ

Taro Pharmaceutical Industries (TARO) currently reports a current cash of $360M as of March 2024. That compares with $150M in the prior-year period — up 134.9% year over year. Use the charts on this page to explore Taro Pharmaceutical Industries's current cash history and peer comparisons.

Taro Pharmaceutical Industries's current cash increased from $150M to $360M — a 134.9% year-over-year increase (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Taro Pharmaceutical Industries reported $360M in current cash as of March 2024. That compares with $150M in the prior-year period — up 134.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $360M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Taro Pharmaceutical Industries, and consider following TARO for alerts when major investors trade the stock.

Taro Pharmaceutical Industries is classified in the Healthcare sector. On current cash, it currently shows $360M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TARO with unrelated industries.